55.96 +0.00 (0.00%)
MYGN
Stock Details
Last Trade:55.96 Change:+0.00 (0.00%) Prev Close:55.96 Open: 56.73 Days Range:54.00 – 58.24 52 Week Range: 34.35 - 69.14 Volume:2257111 P/E: 54.86EPS:1.02
View AllRecent Alerts 10/13/08
Recent Alert on 10/08/08 at 10:02am
Notable Analyst Rating Changes 10/08: BMY, NUE, SYMC Upgraded; TM, X, UPS, F, GM Downgraded
Notable Analyst Rating Changes 10/08: BMY, NUE, SYMC Upgraded; TM, X, UPS, F, GM Downgraded
UPGRADES: Merrill Lynch upgrades Bristol-Myers Squibb Co. (NYSE: BMY) from Underperform to Buy, citing valuation. Morgan Stanley upgrades Nucor (NYSE: NUE) from Equal-weight to Overweight. J.P. Morgan upgrades Symantec (Nasdaq: SYMC) from... Read More
Recent Alert on 10/08/08 at 7:37am
Oppenheimer Initiates Coverage on Myriad Genetics (MYGN) with an Outperform
Oppenheimer Initiates Coverage on Myriad Genetics (MYGN) with an Outperform
Recent Alert on 09/17/08 at 8:50am
Myriad Genetics (MYGN) Announces Topline Results of Phase 1 Trial of Vivecon for HIV
Myriad Genetics (MYGN) Announces Topline Results of Phase 1 Trial of Vivecon for HIV
Recent Alert on 09/17/08 at 8:50am
Myriad Genetics (MYGN) Announces Topline Results of Phase 1 Trial of Vivecon for HIV
Myriad Genetics (MYGN) Announces Topline Results of Phase 1 Trial of Vivecon for HIV
Recent Alert on 09/11/08 at 7:48am
Myriad Genetics (MYGN) Reviewing Separating Diagnostic and Pharamceutical Units
Myriad Genetics (MYGN) Reviewing Separating Diagnostic and Pharamceutical Units
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 10/08/08 at 7:43am
Top Pre-Market Analyst Upgrades (AMAG, ANDE, BAC, BMC, CDNS, CTXS, IPAR, JEF, MDR, MYGN, NUVA, SYMC)
Top Pre-Market Analyst Upgrades (AMAG, ANDE, BAC, BMC, CDNS, CTXS, IPAR, JEF, MDR, MYGN, NUVA, SYMC)